Illustrative image – not actual.Shantha Biotechnics has plans to reportedly, raise US$ 25 million (approx. Rs.120 crore) by selling a stake to new investors.
According to Managing Director and company founder,
Mr Varaprasad Reddy, the funds would be used to build a US Drug
Administration-approved plant to make new products.
In September 2000, Morgan Stanley and the State Bank
of India paid $11 million for a combined 6.9 per cent holding.
Shantha Biotechnics was founded in 1992 with US$ 7
lakh (approx. Rs.336 lakh) in seed money, half from Reddy and 3 US-based Indian
partners and the remainder from the foreign minister of Oman and associates.
